Your Key to the GxP Market: How SaaS Providers make their Software Solutions ready for regulated Industries
Many software companies see great potential in the pharma, MedTech, and biotech industries. However, success in regulated environments requires more than technology: GxP compliance must be understood and implemented. Our web session showed how SaaS providers can prepare and unlock new market opportunities.
What does GxP actually mean?
GxP stands for Good Practices and refers to quality guidelines that are binding in the life sciences industry. These include:
- GMP (Good Manufacturing Practice) – manufacturing processes
- GLP (Good Laboratory Practice) – laboratory processes
- GCP (Good Clinical Practice) – clinical trials
IT systems that support GxP-critical processes are part of the user company’s GxP-regulated system. The closer an IT system is to critical processes such as manufacturing, quality control, or product release, the stricter the requirements for validation, security, and documentation.
Challenges for GxP-regulated companies
Many SaaS providers pursue a cloud-first strategy but encounter new hurdles in the regulated environment. For SaaS providers, it is important to understand the challenges and questions of GxP-regulated companies:
- How can customers build trust in the SaaS provider?
- How can the SaaS solution be introduced in a validated manner and operated in a valid state?
- Is controlled and documented operation of the SaaS solution ensured?
While the regulated company bears overall responsibility (accountability), the SaaS provider is responsible for operational implementation (responsibility).
This means: All processes must be documented, verifiable, and auditable, from software development through support processes to exit strategies or security certificates (e.g., ISO 27001).
Requirements for Software Providers in the GxP Environment
SaaS providers are not themselves considered “regulated companies,” but they must ensure that their software is developed and operated according to recognized industry standards. These include:
- An established QMS (Quality Management System)
- Structured development and testing processes
- Change and release management
- Subcontractor management
- Traceable operational and support processes
Ready for the GxP Market –
DHC's Two-Stage Process Model
Based on multiple projects with software and SaaS providers, DHC has developed a proven approach to prepare companies efficiently and successfully for entering the GxP-regulated market:
Phase 1: Establishing the Foundation
- Definition of relevant quality and compliance requirements
- Conducting a GAP analysis
- Derivation and implementation of specific measures
- Establishing a functional QMS
- Optional: conducting a friendly audit
Phase 2: Increasing Efficiency and Transparency
- Preparation of compliance documentation (e.g. supplier qualification packages, whitepapers)
- Description of architecture, security and quality concepts
- Provision of pre-filled questionnaires, certifications and attestations to accelerate the sales process
This structured approach enables companies to meet regulatory requirements proactively and builds trust with customers, auditors and regulatory authorities.
Conclusion: Compliance as a catalyst for growth
GxP compliance is not an obstacle but a strategic opportunity for SaaS providers.
Those who set up their processes and products in a regulatory-compliant manner can not only open up new markets but also build long-term trust.
With the support of experienced partners such as DHC, entering the life sciences market succeeds safely, efficiently, and sustainably.
Because: Compliance by Design means future-proofing and is the key to sustainable success in the regulated environment.
SaaS Solutions in GxP-Regulated Industries
How SaaS providers make their software solutions ready for the life sciences.
